MYMENTUM Trademark

Trademark Overview


On Thursday, October 29, 2020, a trademark application was filed for MYMENTUM with the United States Patent and Trademark Office. The USPTO has given the MYMENTUM trademark a serial number of 90287781. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 14, 2022. This trademark is owned by Gilead Sciences, Inc.. The MYMENTUM trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

financial administration of pharmacy reimbursement programs and patient medication costs, namely, assisting patients, pharmacists, and healthcare providers with respect to reimbursement of medicines

promoting public awareness of treatment guidelines; promoting public awareness of inflammatory and autoimmune diseases; assisting patients in enrolling in pharmaceutical reimbursement and benefit programs

information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatment, including such services provided on-line from a computer network or the Internet; providing information and advisory services regarding the diagnosis and treatment of diseases and medical disorders
mymentum

General Information


Serial Number90287781
Word MarkMYMENTUM
Filing DateThursday, October 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 15, 2021

Trademark Statements


Pseudo MarkMY MOMENTUM
Goods and Servicesfinancial administration of pharmacy reimbursement programs and patient medication costs, namely, assisting patients, pharmacists, and healthcare providers with respect to reimbursement of medicines
Goods and Servicespromoting public awareness of treatment guidelines; promoting public awareness of inflammatory and autoimmune diseases; assisting patients in enrolling in pharmaceutical reimbursement and benefit programs
Goods and Servicesinformation and advisory services relating to pharmaceuticals, diseases and medical conditions and treatment, including such services provided on-line from a computer network or the Internet; providing information and advisory services regarding the diagnosis and treatment of diseases and medical disorders

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2020
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Party NameGilead Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFoster City, CA 94404

Trademark Events


Event DateEvent Description
Monday, March 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 10, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 15, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 26, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 6, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 22, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 22, 2021NON-FINAL ACTION E-MAILED
Thursday, April 22, 2021NON-FINAL ACTION WRITTEN
Thursday, April 22, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 16, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, February 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 27, 2021ASSIGNED TO EXAMINER
Tuesday, December 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 2, 2020NEW APPLICATION ENTERED IN TRAM